The Limits of Altruism A Global Scramble for the Coming Coronavirus Vaccine

A vast rivalry is developing between the U.S. and China in the race to develop a coronavirus vaccine. The health of billions of people depends on the outcome. How can the vaccine be fairly distributed? By DER SPIEGEL Staff
Graves of COVID-19 victims in the Brazilian city of Manaus

Graves of COVID-19 victims in the Brazilian city of Manaus

Foto: MICHAEL DANTAS / AFP
Inspecting samples at Curevac: A global project

Inspecting samples at Curevac: A global project

Foto: SEBASTIAN GOLLNOW / DPA
Public officials in Beijing: Fears of a second wave

Public officials in Beijing: Fears of a second wave

Foto: ROMAN PILIPEY / EPA-EFE / SHUTTERSTOCK
Trump and Xi in 2019: China is looking far less selfish than the U.S. in this crisis.

Trump and Xi in 2019: China is looking far less selfish than the U.S. in this crisis.

Foto: KEVIN LAMARQUE / REUTERS
The Americans have already ordered 300 million doses of a trial vaccine. The Europeans have ordered 400 million.
Migrant workers in India stranded by the lockdown: Who will be the first to receive the vaccine?

Migrant workers in India stranded by the lockdown: Who will be the first to receive the vaccine?

Foto: ANUSHREE FADNAVIS / REUTERS
The German government says it will provide 750 million euros in support to companies in the development and production of a COVID-19 vaccine in Germany.
DER SPIEGEL 26/2020
Mehr lesen über